INREBIC

This brand name is authorized in Austria, Estonia, France, Croatia, Ireland, Israel, Italy, Lithuania, Poland, Romania, United Kingdom, United States

Active ingredients

The drug INREBIC contains one active pharmaceutical ingredient (API):

1 Fedratinib UNII UH9J2HBQWJ - FEDRATINIB HYDROCHLORIDE

Fedratinib is a kinase inhibitor with activity against wild type and mutationally activated Janus Associated Kinase 2 (JAK2) and FMS-like tyrosine kinase 3 (FLT3). Fedratinib reduced JAK2-mediated phosphorylation of signal transducer and activator of transcription (STAT3/5) proteins, inhibited malignant cell proliferation in vitro and in vivo. Read about Fedratinib

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
INREBIC Hard capsule	European Medicines Agency (EU)	MPI, EU: SmPC
INREBIC Capsule	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01EJ02		L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EJ Janus-associated kinase (JAK) inhibitors
Discover more medicines within L01EJ02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1840799
Country: FR	Base de données publique des médicaments	Identifier(s): 65716809
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 396295
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8773
Country: IT	Agenzia del Farmaco	Identifier(s): 049373018
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1092140
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100448594
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68147001
Country: US	FDA, National Drug Code	Identifier(s): 59572-720